163222-33-1 Ezetimibe 99%
Price | Get Latest Price | |||
Packge | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-05
Product Details
- Product NameEzetimibe
- CAS No.163222-33-1
- EINECS No.682-606-0
- MFC24H21F2NO3
- MW409.43
- AppearancepowderWhite or off-white
- Melting point 164-166°C
- storage temp. 2-8°C
- Boiling point 654.9±55.0 °C(Predicted)
- density 1.334±0.06 g/cm3(Predicted)
Company Profile Introduction
Lupin’s journey is a testament to the potential of human imagination, compassion, and the unwavering pursuit of a better tomorrow. Established in 1968 by our visionary founder, Dr. Desh Bandhu Gupta, Lupin has evolved from humble beginnings to become a global healthcare leader.
Headquartered in Mumbai, India, Lupin is a global pharmaceutical leader with a footprint across the U.S., LATAM, APAC, EMEA and India, with products distributed in over 100 markets. With a diverse portfolio of over 1,200 products, Lupin remains committed to its mission of making quality healthcare accessible to the communities we serve. Our visionary Founder, Dr. Desh Bandhu Gupta, instilled in us the importance of offering quality, affordable and innovative medicines and being a responsible corporate citizen, making a positive difference to patients, communities and the environment.
Lupin has a network of 15 manufacturing sites, 7 research centers, and a dedicated workforce of over 22,000 professionals. The company places emphasis on business excellence, R&D and innovation, patient centricity and quality and compliance to consistently deliver value to our stakeholders. Lupin has also been at the forefront of leveraging digital solutions to serve patient needs.
Supplier other products
Recommended supplier
-
VIP1年
- SETV ASRV LLP
- EZETIMIBE 95-99 %
- Inquiry
- 2024-09-11
-
VIP1年
- AKASH PHARMA EXPORTS
- Ezetimibe 99%
- Inquiry
- 2024-05-16
-
VIP1年
- Molsyns Research
- Ezetimib Reference Standard 98%
- Inquiry
- 2024-04-01
-
VIP1年
- Aspen Biopharma Labs Pvt Ltd
- Ezetimibe 163222-33-1 98%
- Inquiry
- 2024-03-16
-
VIP1年
- Ratnagene lifescience Pvt Ltd
- Ezetimibe 98%
- Inquiry
- 2024-03-16
-
VIP1年
- Mylan Laboratories Ltd
- 163222-33-1 Ezetimibe 98%
- Inquiry
- 2024-03-06
-
VIP1年
- Bondbay Pharmaceuticals Pvt Ltd
- Ezetimibe 163222-33-1 98%
- Inquiry
- 2024-03-05
-
VIP1年
- Vishrudh laboratories pvt ltd
- 163222-33-1 98%
- Inquiry
- 2024-03-01
-
VIP1年
- Ind Swift Laboratories Ltd
- Ezetimibe 163222-33-1 99%
- Inquiry
- 2024-02-24
-
VIP1年
- BDR Pharmaceuticals International Pvt Ltd
- Ezetimibe 98%
- Inquiry
- 2024-02-24
- Since:2020-01-01
- Address: B/4 Laxmi Towers, Bandra Kurla Complex, Bandra (E),Mumbai,Maharashtra